User banner image
User avatar
  • admin

Posts

NaaS Technology Inc. Announces Cancellation of Annual General Meeting Convened for January 25, 2025

BEIJING, Jan. 24, 2025 /PRNewswire/ — NaaS Technology Inc. (Nasdaq: NAAS) (the “Company”), one of the largest and fastest-growing electric vehicle charging service providers in China,...

AMCOR AND BERRY GLOBAL ANNOUNCE IMPORTANT MILESTONE TOWARDS TRANSACTION CLOSING

Joint Proxy Statement Filed with U.S. Securities and Exchange Commission Amcor and Berry Global Shareholder Meetings to take place on 25 February 2025 ZURICH and...

Gift Card and Incentive Cards Market Intelligence: 2025 Annual Subscription for Targeting Strategies, Analysis of Business and Consumer Trends, Consumer Attitude & Behaviour, and Market Innovation

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) — The “Gift Card and Incentive Cards Market Intelligence – Annual Subscription for 40 Countries (Market Size and Forecast...

Global Body Scrub Market to Reach USD 3.6 Billion by 2035, Driven by Rising Skincare Awareness and Growing Demand for Personal Care Products | Future Market Insights, Inc.

The UK body scrub market is experiencing growth driven by rising consumer interest in skincare and self-care routines. A significant factor contributing to this expansion...

Conavi Medical Provides Shareholder Update and 2025 Outlook

– U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026– Evolving medical guidelines position...

SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy

Investor webinar scheduled Tuesday, January 28, 2025, at 8:00 AM EST MIAMI, Jan. 23, 2025 (GLOBE NEWSWIRE) — SAB BIO (Nasdaq: SABS), (“SAB” or the “Company”),...

The Hemp Doctor Unveils Solventless THCA Bubble Hash in Seven Strains

MOORESVILLE, N.C., Jan. 23, 2025 (GLOBE NEWSWIRE) — The Hemp Doctor is thrilled to introduce its latest THCA innovation: THCA Bubble Hash. A solventless concentrate...

Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization efforts Raanana, Israel, Jan. 23, 2025 (GLOBE NEWSWIRE) — Polyrizon Ltd. (the...

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 

STAFFORD, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical...

Tech Mahindra and Wall Street Journal Intelligence Launch ‘The Tech Adoption Index’ Report at WEF 2025

DAVOS, Switzerland, Jan. 23, 2025 /PRNewswire/ — Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to enterprises across industries, has...